This Acceptable Use Policy (“Policy”) governs use of the Victor Evidence website and, where separately approved, the limited research prototype and associated services made available for testing and evaluation of VictorMind and Victor Evidence (the “Research Prototype”). This Policy supplements and is incorporated into the Terms of Use. If you do not agree to comply with this Policy, do not use the Research Prototype.
1. Authorized Research Testing and Evaluation Only
Use the Research Prototype only within the research, testing, evaluation, demonstration, or feedback scope expressly authorized for you. Access does not authorize clinical deployment, patient-care use, commercial deployment, redistribution, sublicensing, or use outside the approved research scope.
2. No Medical Advice or Clinical Decision-Making
Do not use or represent the Research Prototype as a source of medical advice or as an authority for diagnosis, treatment, prescribing, patient management, triage, emergency decisions, or other clinical decision-making. Prototype outputs may be incomplete, inaccurate, unsupported, or inappropriate for a particular situation and must not be relied upon for patient-care or other clinical decisions.
Any medically relevant information must be independently evaluated by appropriately qualified professionals using professional judgment and authoritative sources.
3. No Emergency Use
Do not use or rely on the Research Prototype for emergencies or time-critical medical intervention. If a person may be experiencing a medical emergency, use appropriate emergency services and qualified healthcare channels.
4. Patient, PHI, Confidential, and Sensitive Information
Do not submit patient-identifiable information, protected health information (“PHI”), medical records, confidential patient case details, or other regulated or sensitive personal information through public website forms or any Research Prototype feature that has not been expressly authorized for that purpose.
Prototype access does not by itself establish a HIPAA-compliant environment, a business associate relationship, or authorization to submit PHI. Any use involving regulated or sensitive information requires the applicable technical, contractual, institutional, ethical, privacy, and legal controls to be expressly established beforehand.
5. Account, Activation, and Authenticator Security
- Use only the account assigned to you and only for the scope authorized for you.
- Do not share, sell, transfer, publish, or expose passwords, activation links, authenticator setup secrets, one-time authentication codes, session credentials, or other access credentials.
- Do not allow another person to use your account or impersonate another participant.
- Do not access or attempt to access another user's account, research interactions, VictorMind working context, data, sessions, or administrative functions.
- Do not bypass authentication, authorization, rate limits, security controls, account restrictions, or access boundaries.
- Promptly report suspected unauthorized access, credential compromise, or security vulnerabilities through the Contact page.
6. System and Service Integrity
Do not disrupt, overload, damage, probe, scan, exploit, attack, or interfere with the website, Research Prototype, APIs, databases, infrastructure, evidence sources, authentication systems, or connected services. Do not introduce malware, malicious code, destructive content, or automated activity that threatens security, integrity, availability, or other participants.
7. No Unauthorized Security Testing
Do not perform penetration testing, vulnerability scanning, credential testing, access-control testing, denial-of-service testing, or other security research against the website or Research Prototype without prior written authorization defining the permitted scope and conditions.
8. Proprietary and Patent-Pending Technology
VictorMind and Victor Evidence contain proprietary mathematical and engineered intelligence technology, and patent applications covering aspects of both systems are pending.
Access does not grant permission to copy, reproduce, scrape, extract, reconstruct, disclose, publish, commercialize, or create competing implementations from protected non-public technology. To the extent permitted by applicable law, unauthorized reverse engineering, decompilation, disassembly, reconstruction, extraction of protected theories, equations, methods, architecture, evidence-control processes, source code, or other protected implementation material is prohibited.
Nothing in this Policy restricts a right that applicable law expressly provides and that cannot lawfully be waived or restricted.
9. Automated Extraction, Benchmarking, and Model/System Replication
Do not use automated scraping, systematic prompt extraction, bulk querying, output harvesting, benchmarking designed to expose protected non-public implementation details, model or system extraction, or similar techniques to reconstruct, infer, replicate, or appropriate protected technology except where expressly authorized in writing or required by applicable law.
Ordinary evaluation and good-faith research within the approved testing scope are permitted. This section is intended to protect non-public technology, not to prohibit authorized evaluation.
10. Misrepresentation and Unsupported Claims
Do not represent VictorMind, Victor Evidence, the Research Prototype, or prototype output as clinically validated, medically approved, regulatory approved, certified, guaranteed, error-free, independently verified, or suitable for clinical use unless the specific representation has been independently established and you are authorized to make it.
Do not alter, omit, or present research results, prototype outputs, or evidence in a manner that materially misrepresents what was tested, observed, supported, or concluded.
11. Evidence, Sources, and Output
Do not deliberately remove, falsify, or obscure source attribution, evidence status, or material limitations when doing so would misrepresent an evaluation result. When describing the system or research results, preserve material distinctions among retrieved source evidence, VictorMind reasoning, Victor Evidence evidence control, and language-model-supported interpretation or expression.
Prototype outputs are research artifacts and must not be represented as guaranteed facts, medical instructions, or independently validated clinical conclusions merely because they were produced by the Research Prototype.
12. Unlawful, Deceptive, Abusive, or Harmful Use
Do not use the website or Research Prototype to violate applicable law, commit fraud, impersonate another person, gain unauthorized access, infringe or misappropriate intellectual-property or privacy rights, compromise another person's data or security, evade applicable safeguards, or intentionally create or facilitate patient-safety risks.
13. Research Conduct and Independent Responsibilities
Participants conducting formal research are responsible for determining and obtaining any institutional review, ethics approval, research authorization, informed consent, data-use permission, professional approval, or other requirement applicable to their own activities. Access to the Research Prototype does not provide or substitute for those approvals.
Participants are responsible for complying with their own professional, institutional, contractual, ethical, privacy, security, and legal obligations.
14. Research Data, Confidentiality, and Feedback
During the current limited testing phase, Research Prototype interactions may be temporarily retained or inspected only as described in the Privacy Policy, research notice, consent process, or participation materials and only as reasonably necessary to verify system operation, evidence retrieval and handling, display behavior, debugging, or evaluation. The testing process is not intended to create patient records, patient profiles, a medical-information database, or a permanent repository of participant questions and responses. Temporary testing interaction data is intended to be deleted when it is no longer needed for the applicable testing purpose, subject to separate retention of account, authentication, security, audit, legal, or administrative records where appropriate. Do not intentionally submit third-party confidential information, trade secrets, patient-identifiable information, PHI, medical records, or other information you are not authorized to disclose.
Non-public research materials, restricted prototype functionality, activation information, internal documentation, and other information identified as confidential or reasonably understood to be confidential must not be disclosed outside the authorized research purpose, subject to applicable law and any separate written agreement.
15. No Resale, Transfer, or Unauthorized Commercial Use
Do not sell, rent, sublicense, transfer, redistribute, provide service-bureau access to, or commercially exploit access to the Research Prototype unless expressly authorized in writing. Research access is personal or organizational only to the extent expressly approved.
16. Third-Party Rights and Services
Do not use the Research Prototype in a manner that violates third-party licenses, copyrights, database rights, privacy rights, confidentiality obligations, terms, or other applicable rights. Third-party information and services used or referenced by the Research Prototype remain subject to their applicable rights and limitations.
17. Cooperation With Security and Research Controls
Where reasonably required for security or administration of the research program, approved participants may be required to re-authenticate, reset compromised credentials, comply with updated security instructions, stop prohibited activity, or provide information reasonably necessary to investigate suspected misuse or security incidents, subject to applicable law.
18. Enforcement
Suspected violations may be investigated. Access may be restricted, sessions revoked, accounts disabled, or participation suspended or terminated where reasonably necessary to address security concerns, misuse, unauthorized clinical use, legal or regulatory risk, intellectual-property concerns, patient-safety concerns, violations of research conditions, or violations of this Policy or the Terms of Use.
Enforcement under this Policy does not limit other rights or remedies available under an applicable agreement or law.
19. Changes to This Policy
This Policy may be updated as the Research Prototype, security controls, or research program evolves. The published effective date should be updated when changes are made, and additional notice or consent will be provided where required by applicable law or agreement.
20. Reporting Concerns
Security, privacy, misuse, research-conduct, or policy concerns may be reported through the Contact page.